324 related articles for article (PubMed ID: 37758847)
1. Diagnostic liquid biopsy biomarkers in renal cell cancer.
Zieren RC; Zondervan PJ; Pienta KJ; Bex A; de Reijke TM; Bins AD
Nat Rev Urol; 2024 Mar; 21(3):133-157. PubMed ID: 37758847
[TBL] [Abstract][Full Text] [Related]
2. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
3. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
[TBL] [Abstract][Full Text] [Related]
4. Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers.
Mastrolia I; Catani V; Oltrecolli M; Pipitone S; Vitale MG; Masciale V; Chiavelli C; Bortolotti CA; Nasso C; Grisendi G; Sabbatini R; Dominici M
Biology (Basel); 2023 Jun; 12(6):. PubMed ID: 37372161
[TBL] [Abstract][Full Text] [Related]
5. Cancer Stem Cell Derived Extracellular Vesicles with Self-Functionalized 3D Nanosensor for Real-Time Cancer Diagnosis: Eliminating the Roadblocks in Liquid Biopsy.
Haldavnekar R; Venkatakrishnan K; Tan B
ACS Nano; 2022 Aug; 16(8):12226-12243. PubMed ID: 35968931
[TBL] [Abstract][Full Text] [Related]
6. Prognostic urinary miRNAs for the assessment of small renal masses.
Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
[TBL] [Abstract][Full Text] [Related]
7. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
[TBL] [Abstract][Full Text] [Related]
8. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
9. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
[TBL] [Abstract][Full Text] [Related]
10. Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal Masses.
Žalimas A; Kubiliūtė R; Žukauskaitė K; Sabaliauskaitė R; Trakymas M; Letautienė S; Kaubrienė EM; Ušinskienė J; Ulys A; Jarmalaitė S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555747
[TBL] [Abstract][Full Text] [Related]
11. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.
Finelli A; Cheung DC; Al-Matar A; Evans AJ; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chin JL; Fleshner NE; Haider MA; Kachura JR; Sykes J; Jewett MAS
Eur Urol; 2020 Sep; 78(3):460-467. PubMed ID: 32680677
[TBL] [Abstract][Full Text] [Related]
12. Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature.
Campi R; Stewart GD; Staehler M; Dabestani S; Kuczyk MA; Shuch BM; Finelli A; Bex A; Ljungberg B; Capitanio U
Eur Urol Oncol; 2021 Feb; 4(1):22-41. PubMed ID: 33408053
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
14. Current status of renal biopsy for small renal masses.
Ha SB; Kwak C
Korean J Urol; 2014 Sep; 55(9):568-73. PubMed ID: 25237457
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of small renal masses: the role for molecular biology.
Kurban G; Gedye C; Morales C; Yousef GM; Almatar A; Jewett MA
Arch Esp Urol; 2013 Jun; 66(5):505-16. PubMed ID: 23793768
[TBL] [Abstract][Full Text] [Related]
16. Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.
Zhong ME; Chen Y; Xiao Y; Xu L; Zhang G; Lu J; Qiu H; Ge W; Wu B
EBioMedicine; 2019 Dec; 50():211-223. PubMed ID: 31753726
[TBL] [Abstract][Full Text] [Related]
17. Rationale for percutaneous biopsy and histologic characterisation of renal tumours.
Volpe A; Finelli A; Gill IS; Jewett MA; Martignoni G; Polascik TJ; Remzi M; Uzzo RG
Eur Urol; 2012 Sep; 62(3):491-504. PubMed ID: 22633318
[TBL] [Abstract][Full Text] [Related]
18. Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma.
Glennon KI; Maralani M; Abdian N; Paccard A; Montermini L; Nam AJ; Arseneault M; Staffa A; Jandaghi P; Meehan B; Brimo F; Tanguay S; Rak J; Riazalhosseini Y
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830979
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Extracellular Vesicle and Contaminant Markers in Blood Derivatives Using Multiple Reaction Monitoring.
Newman LA; Useckaite Z; Wu T; Sorich MJ; Rowland A
Methods Mol Biol; 2023; 2628():301-320. PubMed ID: 36781794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
